Carolina Health Specialists Clinical Research Department is a multi-specialty research department that conducts Phase II, III, and IV trials. We are dedicated to providing patients the opportunity to participate in clinical trials with up-to-date treatments, many of which offer new medications to treat a variety of conditions.
Current Studies Include:
Novo Nordisk NN9924-4257 Pioneer 7: Efficacy and Safety of Oral Semaglutide using a Flexible Dose adjustment based on Clinical Evaluation versus Sitagliptin in Subjects with Type 2 Diabetes Mellitus (CLOSED TO SCREENING)
Novo Nordisk NN9924-4221- Pioneer 6: A trial investigating the cardiovascular safety of oral semaglutide in subjects with Type 2 Diabetes Mellitus.
GSK GLP116174 Harmony Outcomes: A long term, randomized, double blind, placebo-controlled study to determine the effect of albiglutide, when added to standard blood glucose lowering therapies, on major cardiovascular events in patients with Type 2 diabetes Mellitus.(CLOSED TO SCREENING)
Novo Nordisk NN2211-4315: Liraglutide versus placebo as add-on to SGLT2 inhibitors.
Sanofi Aventis- EFC11570 - Odyssey Outcomes: a randomized, double-blind, Placebo controlled, Parallel-group study to evaluate the effect of alirocumab on the Occurrence of Cardiovascular Events in Patients who have recently experienced an Acute Coronary Syndrome (CLOSED TO SCREENING)
Boehringer Ingerheim- BI1245.72- EASE 3: A Phase 3, randomized, double blind, placebo-controlled, parallel group, efficacy, safety and tolerability trial of one daily, oral dosed of Emagliflozin as Adjunctive to Insulin Therapy over 26-weeks in patients with Type 1 Diabetes Mellitus. (CLOSED TO SCREENING)
Comparative and Pragmatic Study of Simponi Aria versus Remicade in Rheumatoid Arthritis: An Infusion Study for those with Rheumatoid Arthritis. (Janssen Research & Development)
Prospective Outcomes Study: Vectra DA Guided Care Compared to Usual Care: A study for those with Rheumatoid Arthritis. (Crescendo Bioscience)
Mary Green - Clinical Research Coordinator
Judy Hammond, RN, BSN – Study Coordinator
Irena Ross, CMA - Study Coordinator
If you have been diagnosed with any of the above mentioned health conditions including Rheumatoid and Type 1 or 2 Diabetes and are interested in learning more about available clinical studies, please contact us at